Press Release


AQUARO BIOSYSTEMS ANNOUNCES NEW EXECUTIVE CHAIRMAN
Life Science Industry Serial-Investor Jack Ball to Assume Role of Executive Chairman

January 16, 2017
Aquaro Biosystems announces new executive chairman Jack Ball
Ann Arbor, MI: Aquaro Biosystems, an innovator of devices to streamline the histology workflow, announced today that Jack Ball has been appointed as the company’s Executive Chairman. In this role, Mr. Ball will advise the company during commercialization of the PaceSetter™ Section Mounting System while continuing to serve on the company’s board of directors.

Mr. Ball brings a strong track record of life sciences leadership and a strong background in commercial operations in the life sciences. Currently, he leads Solulink, Inc. as its Chief Executive Officer. Solulink is a life sciences tools company that develops, manufactures, and markets proprietary next generation linking technologies. Mr. Ball is also President of Tyball Associates, LLC, and an Adjunct Professor at the University of Michigan, Ross Business School in Entrepreneurial Studies. Previously, Mr. Ball served as Chief Commercial Officer of Accuri Cytometers, Inc. from the commercialization of its first product through its acquisition by BD Biosciences in 2011. Prior to joining Accuri, he was CEO of Amnis Corporations. Mr. Ball also served as Chief Commercial Officer for Molecular Probes, Inc. (acquired by Life Technologies). Prior to Molecular Probes, Mr. Ball was the Senior VP & General Manager of the Life Sciences Group at Orchid Biosciences, and a senior executive at Amersham Pharmacia Biotech Inc., where he rose to President, North America.

Mr. Ball also serves on the board of directors of several life science companies, including Swift Biosciences, ViroCyt, NanoCellect, Wasatch Microfluidics, ENT Biotech Solutions, DNA Software and CelSee Diagnostics, as well as the non-profit organization the Association of Commercial Professionals (ACP-LS).

“We are pleased to welcome Jack’s increased involvement in Aquaro Biosystems’ commercialization operations as Executive Chairman,” said Alberto Elli, Aquaro Biosystems’ CEO. “Jack has a demonstrated track record in developing, launching, and growing successful products and companies in the life sciences space.”

Mr. Ball stated, “Aquaro Biosystems has an exciting product that automates the last manual step in histology. I am looking forward to further helping the team as Executive Chairman prepare for the commercial launch of the PaceSetter.”

Aquaro Biosystems’ first product, the PaceSetter Section Mounting System, is the first benchtop instrument to automate the last manual step in the histology workflow: the transfer of paraffin-embedded tissue sections directly from microtomes to glass slides. By using a gentle water stream in place of the manual and time-consuming process of transferring sections to slides by hand, the PaceSetter improves histology laboratory efficiency, standardizes section placement, and enhances laboratory ergonomics by making microtomy hands-free.

About Aquaro Biosystems: Aquaro Biosystems is an Ann Arbor, MI-based company that develops user-centric products to streamline the histology workflow. The company is currently working on various histology products that will integrate into its PaceSetter suite. For more information, or to contact us, please visit www.aquarobio.com.

Click to download a pdf of this press release and contact us for more information.